E-LIB Suche - Ergebnisse für: Passardi, A.

1

423P Multicentre, multi-cohort, single-arm phase II trial o..:

Raimondi, A. ; Lonardi, S. ; Murgioni, S....
Annals of Oncology. 35 (2024) - p. S172 , 2024

Link: https://doi.org/10.1016/..

2

73P Efficacy outcomes in ≥70-year-old or younger patients r..:

Signorelli, C. ; Calegari, M.A. ; Basso, M....
Annals of Oncology. 35 (2024) - p. S35 , 2024

Link: https://doi.org/10.1016/..

3

113P p16 immunohistochemical (IHC) expression (exp) predict..:

Studiale, V. ; Germani, M.M. ; Moretto, R....
Annals of Oncology. 35 (2024) - p. S53 , 2024

Link: https://doi.org/10.1016/..

4

Treatment of patients with BRAF-mutated metastatic colorect..:

Germani, M.M. ; Vetere, G. ; Santamaria, F....
ESMO Open. 9 (2024) 4 - p. 102996 , 2024

Link: https://doi.org/10.1016/..

5

112P The presence of liver metastases does not predict resi..:

Carullo, M. ; Antoniotti, C. ; Rossini, D....
Annals of Oncology. 35 (2024) - p. S52 , 2024

Link: https://doi.org/10.1016/..

6

274P Utility of MRI-based radiomic metrics and circulating ..:

Marisi, G. ; Molinari, C. ; Feliciani, G....
Annals of Oncology. 35 (2024) - p. S115 , 2024

Link: https://doi.org/10.1016/..

7

Phase II study of capecitabine-based concomitant chemoradia..:

Grassi, E. ; Zingaretti, C. ; Petracci, E....
ESMO Open. 8 (2023) 5 - p. 101824 , 2023

Link: https://doi.org/10.1016/..

8

Bone metastases are associated with worse prognosis in pati..:

Dell'Aquila, E. ; Rossini, D. ; Fulgenzi, C.A.M....
ESMO Open. 7 (2022) 6 - p. 100606 , 2022

Link: https://doi.org/10.1016/..

9

Encorafenib plus cetuximab with or without binimetinib in p..:

Boccaccino, A. ; Borelli, B. ; Intini, R....
ESMO Open. 7 (2022) 3 - p. 100506 , 2022

Link: https://doi.org/10.1016/..

10

Prognostic and predictive impact of consensus molecular sub..:

Borelli, B. ; Fontana, E. ; Giordano, M....
ESMO Open. 6 (2021) 2 - p. 100073 , 2021

Link: https://doi.org/10.1016/..

11

Treatment of squamous cell carcinoma of the anal canal: A n..:

Casadei Gardini, A. ; Passardi, A. ; Fornaro, L....
Critical Reviews in Oncology/Hematology. 123 (2018) - p. 52-56 , 2018

Link: https://doi.org/10.1016/..

12

Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemo..:

Giordano, G. ; Lo Re, G. ; Milella, M....
European Journal of Cancer. 72 (2017) - p. S87 , 2017

Link: https://doi.org/10.1016/..

13

2335 Analysis of activity, efficacy and safety of first lin..:

Giordano, G. ; De Vita, F. ; Melisi, D....
European Journal of Cancer. 51 (2015) - p. S445 , 2015

Link: https://doi.org/10.1016/..

14

Locoregional Hypofractionated Radio-Chemotherapy for Unrese..:

Romeo, A. ; Parisi, E. ; Passardi, A....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 1 - p. S357 , 2014

Link: https://doi.org/10.1016/..

15

Hypofractionated Chemoradiation Therapy With Gemcitabine Pl..:

Romeo, A. ; Parisi, E. ; Passardi, A....
International Journal of Radiation Oncology*Biology*Physics. 87 (2013) 2 - p. S307 , 2013

Link: https://doi.org/10.1016/..